Abstract
Abstract: A medication that can be used to treat inflammation caused by allergies andasthma, omalizumab, is really a special medication. Omalizumab’s efficacy has been previously tested in both real-life and controlled settings, in previous studies. In those studies Omalizumab is found to be both safe and efficient, for asthma and allergies, evenfor prolonged usage. But my question is, how this safety and efficiency is maintained in omalizumab throughout its manufacturing process. Here, I will be looking at and explaining the process of how omalizumab is maintained, through my insight from an internship at Kashiv Biosciences, a biosimilar pharmaceuticals company
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal for Research in Applied Science and Engineering Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
